TriSalus Life Sciences, Inc.
TLSI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,811 | -$8,288 | -$10,375 | -$10,108 |
| Dep. & Amort. | $163 | $165 | $172 | $193 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,892 | $1,620 | $1,697 |
| Change in WC | $2,387 | -$1,388 | $1,599 | $467 |
| Other Non-Cash | $4,552 | $299 | $2,485 | $2,044 |
| Operating Cash Flow | -$3,709 | -$7,320 | -$4,499 | -$5,707 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$216 | $93 | -$754 | -$50 |
| Net Acquisitions | $40 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $40 | $0 |
| Investing Cash Flow | -$176 | $93 | -$714 | -$50 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6 | -$1 | $9,929 | -$19 |
| Stock Issued | $88 | $22,211 | $0 | $2,951 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1,493 | -$241 | $62 |
| Financing Cash Flow | $82 | $20,717 | $9,688 | $2,994 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,803 | $13,490 | $4,475 | -$2,763 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26,490 | $13,350 | $8,875 | $11,638 |
| End Cash | $22,687 | $26,840 | $13,350 | $8,875 |
| Free Cash Flow | -$3,925 | -$7,227 | -$5,253 | -$5,757 |